Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
7:40 pm - 9:30 pm
Keynote Session: Lysosomal Function in Health and Disease
7:40 pm - 7:45 pm
Introduction by Discussion Leader
7:45 pm - 8:10 pm
"Developing Gene Therapies to Treat Dysfunctional Brain Circuits"
8:10 pm - 8:20 pm
Discussion
8:20 pm - 8:45 pm
"Mechanisms and Consequences of latrogenic Lysosomal Storage"
8:45 pm - 8:55 pm
Discussion
8:55 pm - 9:20 pm
"Intra-Lysosomal Lipid Metabolism and Neurodegeneration"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Lysosomal Protein Function and Disease Mechanisms
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Role of Lysosomal Transporters for Protein Catabolites in Cellular and Organismal Nutrition"
9:30 am - 9:35 am
Discussion
9:35 am - 10:00 am
"Lysosome Dynamics in C. Elegans Development and Aging"
10:00 am - 10:05 am
Discussion
10:05 am - 10:30 am
"Structural Studies of the Lysosomal Multienzyme Complex"
10:30 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
"Decoding Cholesterol-mTORC1 Signaling in Organelle Homeostasis and Neurodegeneration"
11:25 am - 11:30 am
Discussion
11:30 am - 11:45 am
"Mechanosensitive Ion Channel TMEM63 Modulate Lysosomal Morphology and Function"
11:45 am - 11:50 am
Discussion
11:50 am - 12:00 pm
"Investigating the Role of LncRNAs in Lysosome Health and Function"
12:00 pm - 12:05 pm
Discussion
12:05 pm - 12:30 pm
Poster Previews
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Novel Aspects in Lysosome Biology
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
"Interactomics Identifies a Novel Role for the PD/DLB-Linked VPS13C in Non-Canonical mTORC1 Signaling"
8:00 pm - 8:05 pm
Discussion
8:05 pm - 8:30 pm
"Decoding Lysosomal Mechanisms of Cellular Adaptation"
8:30 pm - 8:35 pm
Discussion
8:35 pm - 9:00 pm
"STING Mediates Lysosomal Quality Control and Recovery through its Proton Channel Function and TFEB Activation"
9:00 pm - 9:05 pm
Discussion
9:05 pm - 9:25 pm
"JIP4 Promotes Lysosomal Cystine Efflux by Suppressing TMEM55-Dependent Cystinosin (CTNS) Degradation"
9:25 pm - 9:30 pm
Discussion
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Lysosomal Diseases and What We Learn from Preclinical Studies
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:35 am
"Platform AAV-Based Gene Therapy Approach for Multiple Lysosomal Storage Diseases"
9:35 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Project Butterfly: Making a Personalized Antisense Oligonucleotide Medicine for CLN3 Batten Disease"
10:05 am - 10:15 am
Discussion
10:15 am - 10:30 am
"Combining Stabilized Glucocerebrosidase with a Blood-Brain Barrier Transport Vehicle Enhances Brain Delivery of Active Enzyme in Preclinical Models of Gaucher and Parkinson’s Diseases"
10:30 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:15 am
"Preclinical Studies Evaluating the Biodistribution, Safety, and Pharmacodynamics of LTS-101, a Novel Gene Therapy for CLN2 Batten Disease"
11:15 am - 11:20 am
Discussion
11:20 am - 11:35 am
"Developing a dual AAV gene therapy to treat galactosialidosis and sialidosis using small and large animal models."
11:35 am - 11:40 am
Discussion
11:40 am - 11:55 am
"Systematic analysis of cellular proteomes and lipidomes in lysosomal storage disease."
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:10 pm
"Uncovering the Role of TFEB in Pathogenesis and Disease Progression in Tuberous Sclerosis using Novel Human Kidney Organoid Models"
12:10 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"Spatial and Functional Separation of mTORC Signaling in Response to Different Amino Acid Sources"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Lysosomal Processes and Biomarkers Implicated in the Pathogenesis of Rare and Common Disorders
7:30 pm - 7:40 pm
Introduction by Discussion Leader
7:40 pm - 8:05 pm
"AAV Gene Therapy for Tay-Sachs and Sandhoff Disease: From Mice to Man and a Few Large Animal Models In-Between"
8:05 pm - 8:10 pm
Discussion
8:10 pm - 8:30 pm
"Integrated Multi-Omics Analysis using MENTOR Reveals Metabolic Reprogramming in the Niemann-Pick Type C Mouse Brain"
8:30 pm - 8:35 pm
Discussion
8:35 pm - 8:55 pm
"Cell Autonomous Roles of Galactosylceramidase and Contribution to Krabbe Disease"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:25 pm
"Delineating the Molecular Mechanism Driving Neuroinflammation and Neurodegeneration in CLN3 Disease Pathophysiology"
9:25 pm - 9:30 pm
Discussion
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Therapies for Lysosomal Diseases and Clinical Trials
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Development of Lentiviral Gene Therapy for Pompe Disease and Hunter Syndrome for Transparent and Reasonable Pricing"
9:30 am - 9:35 am
Discussion
9:35 am - 9:55 am
"Technological and Regulatory Hurdles in the Development of Gene Therapy Drugs for Rare Disease"
9:55 am - 10:00 am
Discussion
10:00 am - 10:25 am
"Advances in Our Understanding and Treatment of Niemann-Pick Disease Type C"
10:25 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:20 am
"A Newly Engineered AAV in Non-Human Primates Allows Robust and Therapeutically Relevant Gene Expression to Treat Late Infantile Neuronal Ceroid Lipofuscinosis"
11:20 am - 11:25 am
Discussion
11:25 am - 11:45 am
"Domain-Substituted IGF2 Tag to Modulate Receptor Targeting during Lentiviral Gene Therapy for Mucopolysaccharidosis Type II"
11:45 am - 11:50 am
Discussion
11:50 am - 12:05 pm
"Efficacy of AAV-Mediated Gene Therapy in a Sheep Model of CLN1 Disease"
12:05 pm - 12:10 pm
Discussion
12:10 pm - 12:25 pm
"In House Development of Gene Therapy for Pompe Disease: Preclinical Data and Lessons Learned"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Lysosomes in Neurodegeneration and Underdiagnosed Lysosomal Diseases
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
"Heterozygosity of Lysosomal Enzyme Genes and Adult-Onset Neurodegenerative Disease"
8:00 pm - 8:05 pm
Discussion
8:05 pm - 8:30 pm
"Newly Discovered Glycosylated Metabolites Changing Paradigms of Gaucher Disease"
8:30 pm - 8:35 pm
Discussion
8:35 pm - 9:00 pm
"Key Lysosomal Proteins in Parkinson's Disease Interact to Regulate Polyamine Homeostasis"
9:00 pm - 9:05 pm
Discussion
9:05 pm - 9:25 pm
"Modulation of Neuronal Lysosome Positioning and Function Resolves Alzheimer’s Disease-Linked Pathologies in Cultured Human Neurons"
9:25 pm - 9:30 pm
Discussion
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair(s); Complete the GRC Evaluation Forms; Election of the Next Vice Chair(s)
9:00 am - 12:30 pm
Gene Editing and Novel Therapies for Lysosomal Storage Diseases
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:35 am
"Base Editing and Prime Editing to Correct Disease-Causing Genetic Variants"
9:35 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Somatic Genome Editing as Therapy for Lysosomal Storage Disorders"
10:05 am - 10:10 am
Discussion
10:10 am - 10:30 am
"Novel Therapeutic Strategies for Niemann Pick Type C Disease"
10:30 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:20 am
"Exploring the Pathophysiological Basis of Dysphagia in CLN3 Deficient Mice and the Therapeutic Potential of Gene Therapy"
11:20 am - 11:25 am
Discussion
11:25 am - 11:45 am
"ACTH4-7PGP, a Promising Small Molecule for Treatment of Sanfilippo Disease"
11:45 am - 11:50 am
Discussion
11:50 am - 12:05 pm
"Development of Novel TRPML1 Activators that Modulate Endolysosomal Pathways and Assessment in Disease Models"
12:05 pm - 12:10 pm
Discussion
12:10 pm - 12:25 pm
"Mechanism and rescue of lysosomal defects in Adult-onset Neuronal Ceroid Lipofuscinosis"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Late-Breaking Discoveries in Lysosomal Diseases
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
"Subcellular Separation of Nutrient Signaling to mTORC1"
8:00 pm - 8:05 pm
Discussion
8:05 pm - 8:30 pm
"Novel Human Receptor-Targeted Capsids for CNS Gene Therapy"
8:30 pm - 8:35 pm
Discussion
8:35 pm - 8:55 pm
"Cell-Type Resolved Protein Atlas of Brain Lysosomes Identifies SLC45A1-Associated Disease as a Lysosomal Disorder"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:20 pm
"Identifying and Targeting Novel Lysosomal Enzymes in Pancreatic Cancer"
9:20 pm - 9:25 pm
Discussion
9:25 pm - 9:30 pm
Closing Remarks
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure